Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk.
about
Interventions for induction of mucosal healing in ulcerative colitisInterventions for maintenance of mucosal healing in ulcerative colitisStatus of colitis-associated cancer in ulcerative colitisIntestinal cancer in inflammatory bowel disease: natural history and surveillance guidelinesNod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injuryHistological healing favors lower risk of colon carcinoma in extensive ulcerative colitis.Follow-up endoscopy in gastroenterology: when is it helpful?Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes.An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity indexUlcerative colitis: from inflammation to cancer. Do estrogen receptors have a role?Current management of inflammatory bowel disease and colorectal cancer.Infliximab: the evidence for its place in therapy in ulcerative colitis.Colitis and colorectal cancer.Diagnostic accuracy of confocal laser endomicroscopy in diagnosing dysplasia in patients affected by long-standing ulcerative colitisAdvanced endoscopic imaging for dysplasia surveillance in ulcerative colitis.Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.Non-polypoid colorectal neoplasms: Classification, therapy and follow-upMucosal healing in inflammatory bowel disease-a true paradigm of success?The struggle within: microbial influences on colorectal cancer.Endoscopy in inflammatory bowel disease when and why.Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?Colorectal Cancer in Inflammatory Bowel Disease: Epidemiology, Pathogenesis and SurveillanceThe miR-200 family is increased in dysplastic lesions in ulcerative colitis patients.Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.NF-κB1, NF-κB2 and c-Rel differentially regulate susceptibility to colitis-associated adenoma development in C57BL/6 mice.Usefulness of Endoscopic Indices in Determination of Disease Activity in Patients with Crohn's Disease.The role of TNFalpha in ulcerative colitis.Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis.Predictors of endoscopic inflammation in patients with ulcerative colitis in clinical remissionColorectal cancer surveillance in inflammatory bowel disease: the search continuesChromoendoscopy and Dysplasia Surveillance in Inflammatory Bowel Disease: Past, Present, and Future.Cancer risk in immune-mediated inflammatory diseases (IMID).Characterisation of colonic dysplasia-like epithelial atypia in murine colitis.Balsalazide disodium for the treatment of ulcerative colitis.Colon cancer surveillance in inflammatory bowel disease patients: current and emerging practices.Controversies in mucosal healing in ulcerative colitis.Treatment of steroid-naive ulcerative colitis.The future of molecular approaches to inflammatory bowel disease.Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.
P2860
Q24200747-4C5B1F02-5FB0-419F-BA0F-9AC551B4DB15Q24200760-8E12D4E2-4981-41F4-A8B2-F98BBB8DF8DEQ26751745-4A87AFE1-2ACE-47A7-ADA1-390C1C3911EEQ26826827-90D6BD4D-145B-4033-BCBC-DA5CC8AAFC3DQ28506653-300A2C58-2A15-4590-82F2-06D070C315F5Q33564132-04FA2CA5-4E29-429A-9AB8-98C271EE71DCQ33631352-5A6A3845-D3EF-4F65-8FB8-C20986B428D2Q33819473-C30EF94D-A2F3-48E9-B285-E832F78AA5ACQ33916207-8A717DC2-FD7D-43D1-A06F-06E2A10B7CA9Q34065540-AC862B9F-00D1-4C43-9F9A-56C3829F732CQ34137246-1856DADC-2A72-46C9-8F40-C539D67E6670Q34192660-8FFAF945-E990-440D-A7F2-CA6660E527A2Q34449876-44B4D402-F77B-4219-BE22-209F8ED0C483Q34459879-ABA91CF8-8723-42D1-9016-8198B57EC0E6Q34466583-A3946719-1F1E-41B6-AFEB-E802CCC8BAD4Q34522337-7A97126A-7F93-4ED6-8AC5-9B095F1A9909Q34779205-CA2936E6-2098-44D7-A019-810D617889C9Q35567602-360A287E-774E-4557-8A4F-9E1361E35745Q35749943-AE0C74ED-458C-4AB1-A732-D6B03275ABA9Q36036277-F15B423F-FCD6-4EF0-ABA1-645322F82FF7Q36041075-57BF0BD1-DB7D-4970-B67A-B8D658B4AE28Q36144484-611B5E23-CCEB-45DE-9740-FC5D939A76D0Q36281579-C8FCBEE7-B659-4F53-AC7F-FB5656D4CB76Q36306167-F75AEF99-7B38-4A17-99EF-8201E49D60C1Q36468969-B9E01C52-2659-4C25-BD0D-6B4C5F75BF39Q36532959-FA2DD462-C850-494B-AB93-D97505C0E1E7Q36655221-3C60EBB9-6360-457E-AA3C-19006B2B8221Q36849148-C7F3200B-01B7-427D-A322-6C50045063D2Q36930800-17D5C9D0-48E9-44ED-9CD9-A8B9E47BF7E4Q37111911-797088B5-9898-40F9-A7CB-460A4860C42CQ37122138-6AEABC97-E59F-47DA-90B1-7240C4201099Q37130029-CE9E19FD-240D-4185-87C0-3B3A4894FA6AQ37153407-504D3745-5C18-4ACF-9493-D8AB8E67E181Q37322447-B7D8DCA2-DCE6-4064-A43A-C79C1DF2E2BEQ37345858-FF2440A1-815A-4F4E-917B-323C3DD0626EQ37353103-B57D0AAD-74B3-4574-94D8-A78002B4DB50Q37391543-CB170CD1-050B-4FCC-9409-3E89FC149812Q37483916-C21CCD23-3142-4C60-AF66-F06502141A87Q37587990-1537F4E1-8769-4B55-98E5-9CAA98E7F2E6Q37701805-74903B17-18A7-4841-A457-A7F7CFA9E535
P2860
Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cancer surveillance in longsta ...... nces help predict cancer risk.
@ast
Cancer surveillance in longsta ...... nces help predict cancer risk.
@en
type
label
Cancer surveillance in longsta ...... nces help predict cancer risk.
@ast
Cancer surveillance in longsta ...... nces help predict cancer risk.
@en
prefLabel
Cancer surveillance in longsta ...... nces help predict cancer risk.
@ast
Cancer surveillance in longsta ...... nces help predict cancer risk.
@en
P2093
P2860
P356
P1433
P1476
Cancer surveillance in longsta ...... ances help predict cancer risk
@en
P2093
Saunders BP
Schofield G
Wilkinson KH
Williams CB
P2860
P304
P356
10.1136/GUT.2003.038505
P407
P577
2004-12-01T00:00:00Z